TrialAnnals of the rheumatic diseases2011

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study.

Michael Schiff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.